Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the RNA demethylase FTO for cancer therapy
Linlin Zhou, Hongjiao Xu, Yue Huang, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 5, pp. 1352-1369
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 149
Genetic and epigenetic defects of the RNA modification machinery in cancer
Ines Oršolić, Arnaud Carrier, Manel Esteller
Trends in Genetics (2022) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 66
RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 58
A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO
Gan-qiang Lai, Yali Li, Heping Zhu, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 4, pp. 335-343
Open Access | Times Cited: 14
m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury
Wei-Liang Ke, Zhiwen Huang, Peng Chun-ling, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5443-5452
Open Access | Times Cited: 51
Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents
Sarah Huff, Indrasena Reddy Kummetha, Lingzhi Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10920-10937
Open Access | Times Cited: 46
Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties
Pan Xiao, Zongliang Duan, Zeyu Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9731-9752
Closed Access | Times Cited: 25
Chemical Inhibitors Targeting the Oncogenic m6A Modifying Proteins
Yue Huang, Wenyang Xia, Ze Dong, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 21, pp. 3010-3022
Closed Access | Times Cited: 25
Emerging Role and Mechanism of the FTO Gene in Cardiovascular Diseases
Ziyang Xu, Jing Xia, Xing‐dong Xiong
Biomolecules (2023) Vol. 13, Iss. 5, pp. 850-850
Open Access | Times Cited: 21
MM/GB(PB)SA integrated with molecular docking and ADMET approach to inhibit the fat-mass-and-obesity-associated protein using bioactive compounds derived from food plants used in traditional Chinese medicine
Manisha Mandal, Shyamapada Mandal
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 11, pp. 100435-100435
Open Access | Times Cited: 9
Discovery of Novel RNA Demethylase FTO Inhibitors Featuring an Acylhydrazone Scaffold with Potent Antileukemia Activity
Xuewu Liang, Yue Huang, Hairu Ren, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Structure–Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors
Zeyu Liu, Zongliang Duan, Deyan Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10638-10654
Closed Access | Times Cited: 27
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
Lu Liu, Yuanlai Qiu, Yuying Suo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5382-5392
Open Access | Times Cited: 5
Development of 3-Arylaminothiophenic-2-carboxylic Acid Derivatives as New FTO Inhibitors Showing Potent Antileukemia Activities
Deyan Zhang, Lu Liu, Ming Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117444-117444
Closed Access
A patenting perspective of fat mass and obesity associated protein (FTO) inhibitors: 2017-present
Ze Dong, Yue Huang, Wenyang Xia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
Bo Qin, Qian Bai, Dan Yan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1995-2003
Open Access | Times Cited: 21
Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression
Hongjian Shan, Wenxiang Gu, Gang Duan, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 8038-8050
Open Access | Times Cited: 20
RNA m6A reader IGF2BP3 promotes metastasis of triple‐negative breast cancer via SLIT2 repression
Tongtong Jiang, Xinyi He, Zhining Zhao, et al.
The FASEB Journal (2022) Vol. 36, Iss. 11
Closed Access | Times Cited: 18
Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists
Ranran Zhang, Pengyu Wang, Bingyan Wei, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115577-115577
Closed Access | Times Cited: 10
Structure‐Activity Relationships of 2‐(Arylthio)benzoic Acid FTO Inhibitors
Chao Guo Yan, Qian Zhang, Pan Xiao, et al.
Israel Journal of Chemistry (2024) Vol. 64, Iss. 3-4
Closed Access | Times Cited: 3
A Rhein‐Based Rh(III) Arene Complex with Anti‐tumor Cell Proliferative Activity Inhibits RNA Demethylase FTO
Lu Liu, Yaqiong Kong, Liang He, et al.
Chinese Journal of Chemistry (2022) Vol. 40, Iss. 10, pp. 1156-1164
Closed Access | Times Cited: 16
Dephosphorylation Switch DNAzyme-RCA Circuit: A Robust Strategy for the Homogeneous and Reliable Detection of FTO Demethylase
Taorong Shen, Xing Huang, Yanfei Zhang, et al.
Analytical Chemistry (2023) Vol. 96, Iss. 4, pp. 1686-1692
Closed Access | Times Cited: 8
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents
Noah J. Harrahill, M. Kyle Hadden
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116526-116526
Closed Access | Times Cited: 2
Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
Doris Loh, Rüssel J. Reiter
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8122-8122
Open Access | Times Cited: 13
The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma
Dalin Zhang, Sarah Wornow, Donna M. Peehl, et al.
Translational Oncology (2022) Vol. 25, pp. 101518-101518
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top